In Episode 20 of Science & Chill, I speak with Dr. Henry Henderson. 


 


Dr. Henderson is a post-doctoral fellow in the department of Hematology/Oncology. His research focuses on understanding non-small cell lung cancer and improving therapeutic strategies targeting oncogenic mutations in Epidermal Growth Factor Receptor (EGFR) tyrosine kinase domain with a particular focus on mechanisms of sensitivity and resistance to agents used in clinical practice.


 


Dr. Henderson is also the co-founder of Black in Cancer, an organization that began this year with the goal of "Strengthening Networks and Highlighting Black Excellence in Cancer Research and Medicine."


 


We talk about issues regarding race in academia, medicine, and health disparities. We also talk about Dr. Henderson's research on cancer biology and some exciting projects he's working on. I had a great time speaking with him and I hope you enjoy listening to our conversation.


 


Relevant links:


Follow Dr. Henderson on Twitter


Follow Black in Cancer on Twitter


BlackinCancer.com


Dr. Henderson's VUMC profile page


Support Science & Chill on Patreon


Signup for my Physiology Friday newsletter

Twitter Mentions